{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:40:59Z","timestamp":1787794859312,"version":"build-2784847793"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T00:00:00Z","timestamp":1645833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Opioid use disorder (OUD) affects more than 27 million people globally accounting for more than 300,000 deaths annually. Protracted abstinence among individuals with OUD is rare due to a high relapse rate among those not receiving medications for OUD. Extensive preclinical studies form the basis of the allostasis theory, which proposes long-lasting functional brain abnormalities that persist after opioid withdrawal and contribute to relapse. Few studies have tested the allostasis theory in humans using neuroimaging. Here, we used fMRI and an instrumental learning task to test allostasis theory predictions (ATP) of functional abnormalities in both positive valence (PVS) and negative valence (NVS) accumbens systems in OUD patients with protracted abstinence (<jats:italic>n<\/jats:italic>\u2009=\u200915), comparing them with OUD patients receiving methadone treatment (MT) (<jats:italic>n<\/jats:italic>\u2009=\u200933), and with healthy controls (<jats:italic>n<\/jats:italic>\u2009=\u200923). As hypothesized, protracted abstinence OUD patients showed incomplete recovery of nucleus accumbens function, as evidenced by the blunted response to aversive events (NVS) during negative reinforcement, as observed in MT patients. In contrast, their accumbens response to rewarding events (PVS) during positive reinforcement was similar to that of controls and different from that in MT patients whose response was blunted. Protracted abstinence OUD patients also showed improvements in depression symptoms compared to MT patients. Residual depressive symptoms and pre-MT intravenous drug measures were associated with worse accumbens function in protracted abstinence. These results support the ATP of long-lasting dysfunction of NVS after withdrawal and show preliminary evidence of recovery of PVS function with protracted withdrawal. Therapeutic strategies that target NVS may facilitate recovery.<\/jats:p>","DOI":"10.1038\/s41398-022-01813-4","type":"journal-article","created":{"date-parts":[[2022,2,26]],"date-time":"2022-02-26T04:32:25Z","timestamp":1645849945000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Protracted abstinence in males with an opioid use disorder: partial recovery of nucleus accumbens function"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0740-7893","authenticated-orcid":false,"given":"Serenella","family":"Tolomeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Baldacchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6668-0908","authenticated-orcid":false,"given":"Nora D.","family":"Volkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Douglas","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,26]]},"reference":[{"key":"1813_CR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-019-0135-7","volume":"6","author":"J Strang","year":"2020","unstructured":"Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, et al. Opioid use disorder. Nat Rev Dis Prim. 2020;6:1\u201328.","journal-title":"Nat Rev Dis Prim"},{"key":"1813_CR2","doi-asserted-by":"crossref","unstructured":"MM, Leshner AI. Medications for Opioid Use Disorder Save Lives\u2014National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Health Sciences Policy, Committee on Medication-Assisted Treatment for Opioid Use Disorder. 2019. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK538936\/ (accessed 25 Mar2021).","DOI":"10.17226\/25310"},{"key":"1813_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","volume":"167","author":"T Insel","year":"2010","unstructured":"Insel T, Cuthbert B, Garvey M, Heinssen R, Pine DS, Quinn K, et al. Research Domain Criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry. 2010;167:748\u201351.","journal-title":"Am J Psychiatry"},{"key":"1813_CR4","unstructured":"NIMH. (RDoC). National Institute of Mental Health. Behavioral Assessment Methods for RDoC Constructs: A Report by the National Advisory Mental Health Council Workgroup on Tasks and Measures for Research Domain Criteria. 2016. https:\/\/www.nimh.nih.gov\/about\/advisory-boards-and-groups\/namhc\/reports\/rdoc_council_workgroup_report_153440.pdf."},{"key":"1813_CR5","doi-asserted-by":"publisher","unstructured":"Tolomeo S, McFarlane JA, Baldacchino A, Koob GF, Steele JD. Alcohol binge drinking: negative and positive valence system abnormalitier. Biol Psychiatry Cogn Neurosci Neuroimaging. 2020. https:\/\/doi.org\/10.1016\/j.bpsc.2020.09.010.","DOI":"10.1016\/j.bpsc.2020.09.010"},{"key":"1813_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/S0893-133X(00)00195-0","volume":"24","author":"G Koob","year":"2001","unstructured":"Koob G, Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology. 2001;24:97\u2013129.","journal-title":"Neuropsychopharmacology"},{"key":"1813_CR7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1037\/h0036128","volume":"81","author":"RL Solomon","year":"1974","unstructured":"Solomon RL, Corbit JD. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol Rev. 1974;81:119\u201345.","journal-title":"Psychol Rev"},{"key":"1813_CR8","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2006.12.019","volume":"89","author":"JD Wines","year":"2007","unstructured":"Wines JD, Saitz R, Horton NJ, Lloyd-Travaglini C, Samet JH. Overdose after detoxification: a prospective study. Drug Alcohol Depend. 2007;89:161\u20139.","journal-title":"Drug Alcohol Depend"},{"key":"1813_CR9","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biopsych.2019.05.023","volume":"87","author":"GF Koob","year":"2020","unstructured":"Koob GF. Neurobiology of opioid addiction: opponent process, hyperkatifeia, and negative reinforcement. Biol Psychiatry 2020;87:44\u201353.","journal-title":"Biol Psychiatry"},{"key":"1813_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev.psych.59.103006.093548","volume":"59","author":"GF Koob","year":"2008","unstructured":"Koob GF, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol. 2008;59:29\u201353.","journal-title":"Annu Rev Psychol"},{"key":"1813_CR11","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.biopsych.2019.07.027","volume":"87","author":"L Welsch","year":"2020","unstructured":"Welsch L, Bailly J, Darcq E, Kieffer BL. The negative affect of protracted opioid abstinence: progress and perspectives from rodent models. Biol Psychiatry 2020;87:54\u201363.","journal-title":"Biol Psychiatry"},{"key":"1813_CR12","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/10550887.2011.581985","volume":"30","author":"LM Carcoba","year":"2011","unstructured":"Carcoba LM, Contreras AE, Cepeda-Benito A, Meagher MW. Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals. J Addict Dis. 2011;30:258\u201370.","journal-title":"J Addict Dis"},{"key":"1813_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fpsyt.2019.00117","volume":"10","author":"JL Stewart","year":"2019","unstructured":"Stewart JL, May AC, Aupperle RL, Bodurka J. Forging neuroimaging targets for recovery in opioid use disorder. Front Psychiatry 2019;10:117.","journal-title":"Front Psychiatry"},{"key":"1813_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1038\/npp.2013.289","volume":"39","author":"VB Gradin","year":"2014","unstructured":"Gradin VB, Baldacchino A, Balfour D, Matthews K, Steele JD. Abnormal brain activity during a reward and loss task in opiate-dependent patients receiving methadone maintenance therapy. Neuropsychopharmacology. 2014;39:885\u201394.","journal-title":"Neuropsychopharmacology"},{"key":"1813_CR15","first-page":"1391","volume":"271","author":"G Schulteis","year":"1994","unstructured":"Schulteis G, Markou A, Gold LH, Stinus L, Koob GF. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. J Pharmacol Exp Ther. 1994;271:1391\u201398.","journal-title":"J Pharmacol Exp Ther"},{"key":"1813_CR16","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","volume":"35","author":"DR Wesson","year":"2003","unstructured":"Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoact Drugs. 2003;35:253\u20139.","journal-title":"J Psychoact Drugs"},{"key":"1813_CR17","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:22\u201333. Suppl 2, quiz 34\u201357","journal-title":"J Clin Psychiatry"},{"key":"1813_CR18","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361\u201370.","journal-title":"Acta Psychiatr Scand"},{"key":"1813_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/BF00846549","volume":"12","author":"KO Fagerstrom","year":"1989","unstructured":"Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1989;12:159\u201382.","journal-title":"J Behav Med."},{"key":"1813_CR20","unstructured":"Nelson H, Willison J. The revised national adult reading test\u2013test manual. Wind NFER-Nelson. 1991."},{"key":"1813_CR21","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1093\/jat\/16.3.172","volume":"16","author":"DA Armbruster","year":"1992","unstructured":"Armbruster DA, Krolak JM. Screening for drugs of abuse with the Roche ONTRAK assays. J Anal Toxicol. 1992;16:172\u20135.","journal-title":"J Anal Toxicol"},{"key":"1813_CR22","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1017\/S0033291716001513","volume":"46","author":"S Tolomeo","year":"2016","unstructured":"Tolomeo S, Gray S, Matthews K, Steele JD, Baldacchino A. Multifaceted impairments in impulsivity and brain structural abnormalities in opioid dependence and abstinence. Psychol Med. 2016;46:2841\u201353.","journal-title":"Psychol Med"},{"key":"1813_CR23","doi-asserted-by":"publisher","unstructured":"Tolomeo S, Matthews K, Steele D, Baldacchino A Compulsivity in opioid dependence. Prog Neuropsychopharmacol Biol Psychiatry 2018; 81. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.09.007.","DOI":"10.1016\/j.pnpbp.2017.09.007"},{"key":"1813_CR24","doi-asserted-by":"publisher","unstructured":"Tolomeo S, Davey F, Steele JD, Baldacchino AM. Effects of opioid dependence on visuospatial memory and its associations with depression and anxiety. Front Psychiatry 2019; 10. https:\/\/doi.org\/10.3389\/fpsyt.2019.00743.","DOI":"10.3389\/fpsyt.2019.00743"},{"key":"1813_CR25","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1017\/S0033291718003318","volume":"49","author":"A Baldacchino","year":"2019","unstructured":"Baldacchino A, Tolomeo S, Balfour DJ, Matthews K. Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations. Psychol Med. 2019;49:1174\u201384.","journal-title":"Psychol Med"},{"key":"1813_CR26","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1093\/brain\/awv177","volume":"138","author":"BA Johnston","year":"2015","unstructured":"Johnston BA, Tolomeo S, Gradin V, Christmas D, Matthews K, Douglas Steele J. Failure of hippocampal deactivation during loss events in treatment-resistant depression. Brain. 2015;138:2766\u201376.","journal-title":"Brain"},{"key":"1813_CR27","unstructured":"NIMH. RDoC Matrix. 2020.https:\/\/www.nimh.nih.gov\/research\/research-funded-by-nimh\/rdoc\/constructs\/rdoc-matrix (accessed 29 May 2021)."},{"key":"1813_CR28","first-page":"75","volume":"17","author":"SD Slotnick","year":"2003","unstructured":"Slotnick SD, Moo LR, Segal JB, Hart J. Distinct prefrontal cortex activity associated with item memory and source memory for visual shapes. Brain Res. 2003;17:75\u201382.","journal-title":"Brain Res"},{"key":"1813_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10610-017-9364-z","volume":"24","author":"NJ Kalk","year":"2018","unstructured":"Kalk NJ, Robertson JR, Kidd B, Day E, Kelleher MJ, Gilvarry E, et al. Treatment and intervention for opiate dependence in the United Kingdom: lessons from triumph and failure. Eur J Crim Policy Res. 2018;24:183\u2013200.","journal-title":"Eur J Crim Policy Res"},{"key":"1813_CR30","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","volume":"326","author":"J Strang","year":"2003","unstructured":"Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. Br Med J. 2003;326:959\u201360.","journal-title":"Br Med J"},{"key":"1813_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.15585\/mmwr.mm6935a1","volume":"69","author":"J O\u2019Donnell","year":"2020","unstructured":"O\u2019Donnell J, Gladden RM, Mattson CL, Hunter CT, Davis NL. Vital signs: characteristics of drug overdose deaths involving opioids and stimulants\u201424 States and the District of Columbia, January\u2013June 2019. MMWR Morb Mortal Wkly Rep. 2020;69:1189\u201397.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1813_CR32","doi-asserted-by":"publisher","unstructured":"Koob GF, Schulkin J. Addiction and stress: an allostatic view. Neurosci Biobehav Rev. 2018. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2018.09.008.","DOI":"10.1016\/J.NEUBIOREV.2018.09.008"},{"key":"1813_CR33","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1006\/nlme.2002.4099","volume":"78","author":"ND Volkow","year":"2002","unstructured":"Volkow ND, Fowler JS, Wang GJ, Goldstein RZ. Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies. Neurobiol Learn Mem. 2002;78:610\u201324.","journal-title":"Neurobiol Learn Mem"},{"key":"1813_CR34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S0893-133X(96)00184-4","volume":"16","author":"GJ Wang","year":"1997","unstructured":"Wang GJ, Volkow ND, Fowler JS, Logan J, Abumrad NN, Hitzemann RJ, et al. Dopamine D2 receptor availability in opiate-dependent subjects before and after naloxone-precipitated withdrawal. Neuropsychopharmacology. 1997;16:174\u201382.","journal-title":"Neuropsychopharmacology"},{"key":"1813_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ejphar.2007.09.042","volume":"579","author":"J Shi","year":"2008","unstructured":"Shi J, Zhao LY, Copersino ML, Fang YX, Chen Y, Tian J, et al. PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users. Eur J Pharm. 2008;579:160\u20136.","journal-title":"Eur J Pharm"},{"key":"1813_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.neuropharm.2008.05.022","volume":"56","author":"ND Volkow","year":"2009","unstructured":"Volkow ND, Fowler JS, Wang GJ, Baler R, Telang F. Imaging dopamine\u2019s role in drug abuse and addiction. Neuropharmacology. 2009;56:3\u20138.","journal-title":"Neuropharmacology"},{"key":"1813_CR37","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/nature05051","volume":"442","author":"M Pessiglione","year":"2006","unstructured":"Pessiglione M, Seymour B, Flandin G, Dolan RJ, Frith CD. Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans. Nature. 2006;442:1042\u20135.","journal-title":"Nature"},{"key":"1813_CR38","doi-asserted-by":"publisher","unstructured":"Syed YY, Keating GM. Extended-release intramuscular naltrexone (VIVITROL \u00d2): a review of its use in the prevention of relapse to opioid dependence in detoxified patients. 2013. https:\/\/doi.org\/10.1007\/s40263-013-0110-x.","DOI":"10.1007\/s40263-013-0110-x"},{"key":"1813_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","volume":"85","author":"GE Alexander","year":"1991","unstructured":"Alexander GE, Crutcher MD, Delong MR. Chapter 6 basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u201cprefrontal\u201d and \u201climbic\u201d functions. Prog Brain Res. 1991;85:119\u201346.","journal-title":"Prog Brain Res"},{"key":"1813_CR40","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neuroscience.2014.04.026","volume":"282","author":"S Nakanishi","year":"2014","unstructured":"Nakanishi S, Hikida T, Yawata S. Distinct dopaminergic control of the direct and indirect pathways in reward-based and avoidance learning behaviors. Neuroscience 2014;282:49\u201359.","journal-title":"Neuroscience"},{"key":"1813_CR41","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/bies.201000042","volume":"32","author":"ND Volkow","year":"2010","unstructured":"Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F, Baler R. Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain\u2019s control circuit. BioEssays 2010;32:748\u201355.","journal-title":"BioEssays"},{"key":"1813_CR42","doi-asserted-by":"publisher","first-page":"108129","DOI":"10.1016\/j.neuropharm.2020.108129","volume":"172","author":"MM McGinnis","year":"2020","unstructured":"McGinnis MM, Parrish BC, McCool BA. Withdrawal from chronic ethanol exposure increases postsynaptic glutamate function of insular cortex projections to the rat basolateral amygdala. Neuropharmacology. 2020;172:108129.","journal-title":"Neuropharmacology"},{"key":"1813_CR43","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/nrn2994","volume":"12","author":"AJ Shackman","year":"2011","unstructured":"Shackman AJ, Salomons TV, Slagter HA, Fox AS, Winter JJ, Davidson RJ. The integration of negative affect, pain and cognitive control in the cingulate cortex. Nat Rev Neurosci. 2011;12:154\u201367.","journal-title":"Nat Rev Neurosci"},{"key":"1813_CR44","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/brain\/aww069","volume":"139","author":"S Tolomeo","year":"2016","unstructured":"Tolomeo S, Christmas D, Jentzsch I, Johnston B, Sprengelmeyer R, Matthews K, et al. A causal role for the anterior mid-cingulate cortex in negative affect and cognitive control. Brain. 2016;139:1844\u201354.","journal-title":"Brain"},{"key":"1813_CR45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1006\/jtbi.2001.2509","volume":"215","author":"LA Bruins Slot","year":"2002","unstructured":"Bruins Slot LA, Pauwels PJ, Colpaert FC. Sign-reversal during persistent activation in \u03bc-opioid signal transduction. J Theor Biol. 2002;215:169\u201382.","journal-title":"J Theor Biol"},{"key":"1813_CR46","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1016\/j.biopsych.2011.02.012","volume":"69","author":"H Zhou","year":"2011","unstructured":"Zhou H, Xu J, Jiang J. Deep brain stimulation of nucleus accumbens on heroin-seeking behaviors: a case report. Biol Psychiatry 2011;69:e41\u2013e42.","journal-title":"Biol Psychiatry"},{"key":"1813_CR47","doi-asserted-by":"publisher","first-page":"E883","DOI":"10.1227\/NEU.0000000000001248","volume":"78","author":"D De Ridder","year":"2016","unstructured":"De Ridder D, Manning P, Glue P, Cape G, Langguth B, Vanneste S. Anterior cingulate implant for alcohol dependence. Neurosurgery. 2016;78:E883\u2013E893.","journal-title":"Neurosurgery"},{"key":"1813_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrn2555","volume":"10","author":"AD Craig","year":"2009","unstructured":"Craig AD. How do you feel\u2212now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10:59\u201370.","journal-title":"Nat Rev Neurosci"},{"key":"1813_CR49","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neuropharm.2008.07.035","volume":"56","author":"A Verdejo-Garc\u00eda","year":"2009","unstructured":"Verdejo-Garc\u00eda A, Bechara A. A somatic marker theory of addiction. Neuropharmacology 2009;56:48\u201362.","journal-title":"Neuropharmacology"},{"key":"1813_CR50","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1017\/S0140525X11000446","volume":"35","author":"KA Lindquist","year":"2012","unstructured":"Lindquist KA, Wager TD, Kober H, Bliss-Moreau E, Barrett LF. The brain basis of emotion: a meta-analytic review. Behav Brain Sci 2012;35:121\u201343.","journal-title":"Behav Brain Sci"},{"key":"1813_CR51","first-page":"2174","volume":"318","author":"R Rubin","year":"2017","unstructured":"Rubin R. Illicit fentanyl driving opioid overdose deaths. J Am Med Assoc. 2017;318:2174.","journal-title":"J Am Med Assoc"},{"key":"1813_CR52","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/wps.20846","volume":"20","author":"ND Volkow","year":"2021","unstructured":"Volkow ND. The epidemic of fentanyl misuse and overdoses: challenges and strategies. World Psychiatry. 2021;20:195\u20136.","journal-title":"World Psychiatry"},{"key":"1813_CR53","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.biopsych.2019.05.026","volume":"87","author":"RJ Valentino","year":"2020","unstructured":"Valentino RJ, Koroshetz W, Volkow ND. Translating opioid pharmacology from bench to bedside, and back. Biol Psychiatry 2020;87:4\u20135.","journal-title":"Biol Psychiatry"},{"key":"1813_CR54","doi-asserted-by":"publisher","unstructured":"Upadhyay J, Verrico CD, Cay M, Kodele S, Yammine L, Koob GF et al. Neurocircuitry basis of the opioid use disorder\u2013post-traumatic stress disorder comorbid state: conceptual analyses using a dimensional framework. The Lancet Psychiatry 2021. https:\/\/doi.org\/10.1016\/S2215-0366(21)00008-0.","DOI":"10.1016\/S2215-0366(21)00008-0"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01813-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01813-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:11:10Z","timestamp":1669230670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01813-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,26]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1813"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-01813-4","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,26]]},"assertion":[{"value":"11 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The funding sources played no part in the design of the study, analyses, and interpretation of the data, nor paper preparation. The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"81"}}